The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 494.00
Bid: 488.00
Ask: 500.00
Change: 0.00 (0.00%)
Spread: 12.00 (2.459%)
Open: 494.00
High: 494.00
Low: 494.00
Prev. Close: 494.00
BPM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

13 Sep 2022 07:00

RNS Number : 1711Z
B.P. Marsh & Partners PLC
13 September 2022
 

13th September 2022

 

B.P. Marsh & Partners Plc

("B.P. Marsh", the "Company" or the "Group")

 

Trading Update

 

B.P. Marsh, the niche venture capital provider to early stage financial services businesses, is pleased to provide the market with an update on trading for the Group's six month period which ended 31 July 2022 (the "Period").

 

One of the Group's key financial objectives, is the delivery of long-term growth in Net Asset Value. The Group's full year results to 31 January 2022 showed an increase in Net Asset Value to £166.6m (31 January 2021: £149.9m; 31 July 2021: £155.0m). This represented an 11.7% shareholder return (including the payment of a dividend) in the financial year.

 

The Group remains positive regarding meeting its ongoing aims and objectives, and will be reporting its results for the six months to 31 July 2022, on Tuesday 18 October 2022.

 

1. Dividend

 

On 29 July 2022, the Group paid a dividend of £1m (2.78p per share), for the year ending 31 January 2022. This represented a 13.9% increase over the dividend paid in respect of the previous year.

 

The aim is at least to maintain this level of dividend for the next two years.

 

2. General portfolio update

 

The majority of B.P. Marsh's portfolio companies have performed well in the Period, notwithstanding the wider economic challenges.

 

The Group continues to work closely with its investee companies' respective Management Teams, providing advice and support, to assist in long term growth.

 

Kentro Capital Limited ("Kentro") in London and XPT Group LLC ("XPT") in New York, both continue on their strong growth trajectories.

 

Kentro (formerly called Nexus Underwriting Management Limited) achieved Gross Written Premium of c. £368m in its financial year to 31 December 2021 (2020: £309m) and is on track to increase Gross Written Premium to beyond £450m in its financial year ending on 31 December 2022.

 

XPT achieved Gross Written Premium of c. US$400m in its financial year to 31 December 2021 (2020: US$280m) and is on track to increase Gross Written Premium to beyond US$500m in its financial year which ends on 31 December 2022. This projection does not take into account any new acquisitions that it may complete during this period as it continues to explore M&A opportunities, consistent with its strategy.

 

Within the Period XPT acquired Insurance Brokers, Inc. ("IBI"), a wholesale Insurance Broker based in Indianapolis, Indiana. IBI offers its agents a broad range of personal and commercial insurance products and has licences in nine states across the USA.

 

In addition, as previously announced, in June 2022 the Group invested a further US$3.5m (£2.8m) in XPT, of which US$2.8m was in redeemable shares and US$0.7m in equity, increasing B.P. Marsh's shareholding in XPT from 28.18% to 29.15%. This additional investment was raised to repay US$1.5m of loan funding from Madison Capital, and for future deferred consideration payments.

 

During the Period, the Group completed its transaction regarding the disposal of its Spanish business, Summa Insurance Brokerage S.L. to Acrisure España S.L., part of Acrisure LLC, the global financial services business, realising total cash proceeds of £9.6m.

 

Additionally, the Group completed an investment in Denison and Partners Limited ("Denison"). The Group acquired a 40% Cumulative Preferred Ordinary shareholding in Denison, a start-up London-based Lloyd's Insurance Broker, established by Alasdair Ritchie, a market veteran with over 40 years of experience in the Insurance Market.

 

Post-Period end, the Group agreed a AU$1.2m (£0.7m) loan facility available to one of our Australian investments, Agri Services Company PTY Limited ("Agri Services") to enable it to develop and roll out a new crop insurance product. This was drawn down in full in September 2022.

 

B.P. Marsh remains confident that, by continuing with its investment strategy, and working closely with the management teams in which it invests, it will continue with its historic growth trajectory and will deliver attractive returns for investors.

 

3. Market commentary

 

The insurance intermediary sector, in which the Group invests, continues to see rate increases across most of the lines in which its investee companies operate.

 

The pace of these rate increases continues to slow across the industry, although the Group does not anticipate the market returning to the pricing of the last soft market in the short to medium term.

 

With the ongoing conflict in Ukraine, the Group has considered its direct exposure and remains of the view that the business and its underlying investee companies should not be materially adversely affected by the global sanctions in respect of Russia.

 

The Group acknowledges, however, the various macro challenges facing the world economy. These include higher inflation, increased interest rates, political uncertainty and heightened risks of recession across each of the territories in which the Group's portfolio companies operate.

 

It is not yet fully known how these challenges will affect the insurance market. The Group continues to maintain its disciplined approach against this uncertain backdrop. However, it is believed that increased costs will at least be matched by an increase in premium rates in the short to medium term.

 

4. New Business Opportunities

 

As has been reported to the market over the last 18 months, the Group has made a number of realisations which has resulted in an increase in liquidity, with current cash funds of £13.2m, pursuant to the £2.8m follow-on investment in XPT in June 2022, the payment of £1.0m in dividend in July 2022 and a loan of £0.7m to Agri Services in September 2022.

 

Given the Group's increased liquidity and prominence in the sectors in which it specialises, there remains a focus on new business, and the Group has an active pipeline of new business opportunities which are currently being considered, across financial services, with a focus on Insurance Brokers and Managing General Agencies.

5. Outlook

The Group's strong cash position means that it is well placed to take advantage of any attractive new business opportunities, alongside a strong progression of investment opportunities, presenting themselves within the current portfolio.

 

 

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

+44 (0)20 7233 3112

Nominated Adviser & Broker

Panmure Gordon

Atholl Tweedie / Charles Leigh-Pemberton / Ailsa MacMaster

+44 (0)20 7886 2500

Financial PR & Investor Relations

Tavistock

bpmarsh@tavistock.co.uk

Simon Hudson / Tim Pearson

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains fifteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years.

 

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFRASIFLIF
Date   Source Headline
16th Apr 202412:45 pmRNSInvestee Company Update – LEBC Holdings
12th Apr 202411:01 amRNSAward of Shares under Share Incentive Plan
9th Apr 20249:45 amRNSInvestment Update – Pantheon Specialty Limited
8th Apr 20243:07 pmRNSTransfer of Treasury Shares
27th Mar 202412:20 pmRNSInvestment – Devonshire UW Limited
25th Mar 20247:00 amRNSCompletion of Sale and Dividend Declaration
22nd Feb 202410:49 amRNSDirector/PDMR Shareholding
19th Feb 20244:05 pmRNSDirector/PDMR Shareholding
19th Feb 20247:00 amRNSTrading Update
16th Feb 20244:13 pmRNSDirector/PDMR Shareholding
13th Feb 20244:45 pmRNSDirector/PDMR Shareholding
13th Feb 20241:52 pmRNSHolding(s) in Company
9th Feb 20249:25 amRNSDirector/PDMR Shareholding
7th Feb 20243:00 pmRNSInterim Dividend Declaration
6th Feb 202412:31 pmRNSDirector/PDMR Shareholding
23rd Jan 20242:23 pmRNSUse of Proceeds of Sale and Strategy Confirmation
4th Jan 20244:35 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:25 amRNSInvestment – Ai Marine Risk Limited
27th Dec 20237:00 amRNSCorrection - PDMR and Director Dealings
8th Dec 20235:15 pmRNSDirector/PDMR Shareholding
7th Dec 20237:23 amRNSRealisation of Investment
4th Dec 202310:58 amRNSTransaction in Own Shares
30th Nov 202312:56 pmRNSTransaction in Own Shares
29th Nov 20232:29 pmRNSTransaction in Own Shares
27th Nov 202312:48 pmRNSTransaction in Own Shares
24th Nov 20234:15 pmRNSTransaction in Own Shares
23rd Nov 20234:55 pmRNSTransaction in Own Shares
20th Nov 202312:35 pmRNSFurther Information re Share Option Plan
20th Nov 202311:44 amRNSTransaction in Own Shares
15th Nov 20235:33 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSShares Cancellation & New Share Buy-Back Programme
13th Nov 20239:42 amRNSInvestee Company Update disposal by LEBC of Aspira
20th Oct 20236:23 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSHalf-Year Results
11th Oct 20234:05 pmRNSNotice of Half Year Results
10th Oct 20237:00 amRNSCompletion of Sale of Kentro Capital Limited
2nd Oct 202312:05 pmRNSTransaction in Own Shares
25th Sep 202310:28 amRNSTransaction in Own Shares
19th Sep 20233:50 pmRNSTransaction in Own Shares
18th Sep 202311:18 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTrading Statement
14th Sep 20232:49 pmRNSTransaction in Own Shares
11th Sep 20234:29 pmRNSTransaction in Own Shares
7th Sep 20235:32 pmRNSTransaction in Own Shares
5th Sep 20234:24 pmRNSTransaction in Own Shares
4th Sep 20232:48 pmRNSTransaction in Own Shares
1st Sep 20233:13 pmRNSTransaction in Own Shares
30th Aug 20231:58 pmRNSTransaction in Own Shares
29th Aug 20239:03 amRNSTransaction in Own Shares
24th Aug 202312:06 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.